111P Interim biomarker analysis of a phase Ib/II study of anti-TIGIT etigilimab (MPH313) and nivolumab in subjects with select locally advanced or metastatic solid tumors (ACTIVATE)
Autor: | G. Sarikonda, B.K. Wallace, C. Wiesner, S. Krishnan, J.A. Lewicki, A.M. Kapoun |
---|---|
Rok vydání: | 2022 |
Předmět: | |
Zdroj: | Annals of Oncology. 33:S589 |
ISSN: | 0923-7534 |
Databáze: | OpenAIRE |
Externí odkaz: |